The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mabee, C. L.
Right arrow Articles by Thiele, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mabee, C. L.
Right arrow Articles by Thiele, D. L.
The Journal of Immunology, 1998, 160: 5880-5885.
Copyright © 1998 by The American Association of Immunologists

Dipeptidyl Peptidase I and Granzyme A Are Coordinately Expressed During CD8+ T Cell Development and Differentiation1

Christopher L. Mabee, Michael J. McGuire2 and Dwain L. Thiele3

Liver Unit, Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75235

Dipeptidyl peptidase I (DPPI) is a granule protease that plays a requisite role in processing the proenzyme form of the CTL granule serine proteases (granzymes). This study assesses DPPI mRNA and enzyme expression during T lymphocyte ontogeny and CTL differentiation. The most immature CD3-CD4-CD8- thymocytes were found to express >40-fold higher levels of DPPI mRNA, although levels of DPPI enzymatic activity in CD3-CD4-CD8- thymocytes were only modestly higher than those seen for CD4+CD8+ or CD4+CD8- thymocytes. More mature CD8+CD4- thymocytes and CD8+ splenocytes expressed significantly higher levels of DPPI mRNA and enzymatic activity than CD4+CD8+ or CD4+CD8- thymocytes. Granzyme A mRNA expression was observed in DPPI expressing CD3-CD4-CD8- and CD8+CD4- thymocytes and was also observed in CD8+CD4- splenocytes; however, expression was not observed in CD4+CD8+ or CD4+CD8- thymocytes. Both DPPI mRNA and granzyme A mRNA expression in CD8+ T cells decreased to very low or undetectable levels during the first 48 h after allostimulation in MLCs. However, peak levels of both DPPI and granzyme A expression were observed later in the course of CD8+ T cell responses to alloantigen, with DPPI mRNA expression peaking on either day 3 or day 4 and granzyme A expression peaking at the end of a 5-day MLR. These data indicate that DPPI is expressed at all stages of T cell ontogeny and differentiation in which granzyme A mRNA is detected; consequently, DPPI appears to be available for the processing and activation of granzyme A during both CD8+ T cell development and differentiation.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
N. Bidere, M. Briet, A. Durrbach, C. Dumont, J. Feldmann, B. Charpentier, G. de Saint-Basile, and A. Senik
Selective Inhibition of Dipeptidyl Peptidase I, Not Caspases, Prevents the Partial Processing of Procaspase-3 in CD3-activated Human CD8+ T Lymphocytes
J. Biol. Chem., August 23, 2002; 277(35): 32339 - 32347.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. Bhandoola, B. Kithiganahalli, L. Granger, and A. Singer
Programming for cytotoxic effector function occurs concomitantly with CD4 extinction during CD8+ T cell differentiation in the thymus
Int. Immunol., July 1, 2000; 12(7): 1035 - 1040.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.